Compass Pathways has raised $80 million to prepare its psilocybin therapy for phase 3 development. The London-based biotech is advancing the drug, the active ingredient in magic mushrooms, for use in people with treatment-resistant depression.
See Original Article

A drug co-produced by Regeneron (REGN) – Get Report and Sanofi (SNY) – Get Report used to treat rheumatoid arthritis has shown potential to treat patients most stricken with Covid-19, the respiratory disease that afflicts the most affected patients of the …
See Original Article

Live. Amazon has revealed a pilot program that utilizes video conferencing software to vet new third-party sellers hoping to join the platform. CNET Personal Finance. Your Money, Your Future. As tech extends to personal finance, CNET’s experts share news, …
See Original Article

Starting today, the Pennsylvania Liquor Control Board is expanding its curbside service at nearly all of the state’s 600 Fine Wine & Spirits stores and licensee service centers to better meet consumer demand. The expanded list of stores can be found on the …
See Original Article

A Pittsburgh-designed medical device has received federal approval for emergency use in the fight against COVID-19. ALung Technologies Inc., a medical technology startup on the South Side, created its signature Hemolung more than 13 years ago.
See Original Article